EGFR and non-small cell lung carcinoma: MYF-01-37 binds covalently to TEAD and disrupts the YAP-TEAD interaction, enhances EGFR inhibitor-mediated apoptosis, and prevents dormancy in EGFR-mutant non-small cell lung cancer [133].